OLN:NYSEOlin Corporation Analysis

Olin trades at $22.01, well under its 20‑day SMA (≈$25) and 50‑day SMA (≈$26.5), with an RSI of 29 indicating oversold conditions. The MACD histogram is negative, and price sits near the identified support of $21.72, suggesting limited downside but a potential bounce. However, the company reports a negative operating margin and a trailing EPS of –$1.62, with a debt‑to‑equity ratio of roughly 191%, highlighting significant balance‑sheet stress. The dividend yield of 3.63% looks attractive, but a payout ratio of 174% is clearly unsustainable given the current cash flow and earnings profile. Volatility is high at 46% over the past 30 days and beta exceeds 1.2, pointing to heightened price swings.
Analysts’ DCF model values OLN at about $29, implying roughly 37% upside, and consensus price targets sit near $30, driven largely by the announced all‑stock merger with Huntsman that promises $400 million of cost synergies and a combined revenue base of ~$12.5 billion. The merger could improve earnings visibility (forward EPS $0.93) and potentially alleviate debt pressure, but regulatory scrutiny adds uncertainty. Given the mix of technical oversold signals, substantial upside potential, and considerable financial risk, the stock sits in a transitional zone. Investors should weigh the near‑term downside protection against the longer‑term value creation from the merger.